| FORM C | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL |
| OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
| Filer CIK: | 0001139685 |
| Filer CCC: | XXXXXXXX |
| Period: | 12-31-2019 |
| Is this a LIVE or TEST Filing? |  LIVE  TEST |
| Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? |  |
| Would you like a Return Copy? | |
Submission Contact Information
| Name: | |
| Phone Number: | |
| Contact E-Mail Address: | |
| Notify via Filing Website only? | |
Form C: Issuer Information
Issuer Information
| Name of Issuer: | 20/20 GeneSystems, Inc. |
Legal Status of Issuer:
| Form: | Corporation |
| Jurisdiction of Incorporation/Organization: | DELAWARE |
| Date of Incorporation/Organization: | 08-07-2000 |
Physical Address of Issuer:
| Address 1: | 9430 KEY WEST AVE. |
| City: | ROCKVILLE |
| State/Country: | MARYLAND |
| Mailing Zip/Postal Code: | 20850 |
| Website of Issuer: | www.2020gene.com |
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
| Current Number of Employees: | 15.00 |
| Total Assets Most Recent Fiscal Year-end: | 3125886.00 |
| Total Assets Prior Fiscal Year-end: | 4105209.00 |
| Cash and Cash Equivalents Most Recent Fiscal Year-end: | 636018.00 |
| Cash and Cash Equivalents Prior Fiscal Year-end: | 3273494.00 |
| Accounts Receivable Most Recent Fiscal Year-end: | 32498.00 |
| Accounts Receivable Prior Fiscal Year-end: | 15488.00 |
| Short-term Debt Most Recent Fiscal Year-end: | 0.00 |
| Short-term Debt Prior Fiscal Year-end: | 0.00 |
| Long-term Debt Most Recent Fiscal Year-end: | 0.00 |
| Long-term Debt Prior Fiscal Year-end: | 0.00 |
| Revenue/Sales Most Recent Fiscal Year-end: | 288300.00 |
| Revenue/Sales Prior Fiscal Year-end: | 277047.00 |
| Cost of Goods Sold Most Recent Fiscal Year-end: | 263917.00 |
| Cost of Goods Sold Prior Fiscal Year-end: | 217595.00 |
| Taxes Paid Most Recent Fiscal Year-end: | 0.00 |
| Taxes Paid Prior Fiscal Year-end: | 0.00 |
| Net Income Most Recent Fiscal Year-end: | -2425338.00 |
| Net Income Prior Fiscal Year-end: | -1463105.00 |
Form C: Signature
Signature
| Issuer: | 20/20 GeneSystems, Inc. |
| Signature: | Jonathan Cohen |
| Title: | Chief Executive Officer |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
| Signature: | Jonathan Cohen |
| Title: | CEO, President and Director |
| Date: | 07-08-2020 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
| Signature: | Richard M. Cohen |
| Title: | Director |
| Date: | 07-08-2020 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
| Signature: | John W. Rollins |
| Title: | Director |
| Date: | 07-08-2020 |
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
| Signature: | Michael A. Ross |
| Title: | Director |
| Date: | 07-08-2020 |